BIVI Biovie Inc

Price (delayed)

$1.63

Market cap

$12.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.05

Enterprise value

$3.59M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2

BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company’s drug candidate bezisterim ...

Highlights
The EPS has soared by 75% YoY and by 22% from the previous quarter
BIVI's debt is down by 21% YoY and by 7% QoQ
BIVI's quick ratio has plunged by 68% from the previous quarter and by 66% YoY
BIVI's equity is down by 46% year-on-year and by 34% since the previous quarter

Key stats

What are the main financial stats of BIVI

BIVI stock price

How has the Biovie stock price performed over time
Intraday
0%
1 week
-5.23%
1 month
-16.41%
1 year
-11.41%
YTD
40.52%
QTD
-15.98%

Financial performance

How have Biovie's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.65M
Net income
-$22.07M
Gross margin
N/A
Net margin
N/A
The net income is down by 26% year-on-year and by 11% since the previous quarter
The company's operating income fell by 25% YoY and by 10% QoQ

Price vs fundamentals

How does BIVI's price correlate with its fundamentals

Growth

What is Biovie's growth rate over time

Valuation

What is Biovie stock price valuation
P/E
N/A
P/B
1.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 75% YoY and by 22% from the previous quarter
The price to book (P/B) is 79% lower than the 5-year quarterly average of 5.7 but 50% higher than the last 4 quarters average of 0.8
BIVI's equity is down by 46% year-on-year and by 34% since the previous quarter

Efficiency

How efficient is Biovie business performance
The company's return on assets fell by 42% YoY and by 21% QoQ
BIVI's ROE is down by 39% YoY and by 25% QoQ
Biovie's ROIC has decreased by 17% from the previous quarter

Dividends

What is BIVI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BIVI.

Financial health

How did Biovie financials performed over time
BIVI's total liabilities has soared by 109% since the previous quarter and by 56% year-on-year
BIVI's quick ratio has plunged by 68% from the previous quarter and by 66% YoY
BIVI's debt is 97% lower than its equity
BIVI's debt to equity has soared by 50% from the previous quarter and by 50% YoY
BIVI's equity is down by 46% year-on-year and by 34% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.